Document is current
Any future updates will be listed below
-
Authors
Kuroda, Shinji https://orcid.org/0000-0002-4484-1253
Tazawa, Hiroshi
Hashimoto, Masashi
Kanaya, Nobuhiko
Kakiuchi, Yoshihiko
Kagawa, Shunsuke
Urata, Yasuo
Fujiwara, Toshiyoshi
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP25ck0106018h0001)
Okayama University
- License Information
-
More Information
Article History
Received: 8 December 2025
Accepted: 13 February 2026
First Online: 21 February 2026
Declarations
:
: Yasuo Urata is the President and CEO of Oncolys BioPharma, Inc., the manufacturer of OBP-702. Hiroshi Tazawa and Toshiyoshi Fujiwara are consultants of Oncolys BioPharma, Inc. The remaining authors declare no competing interest.
